Investors / United States / Kineticos
Kineticos
Venture capital · Raleigh, NC, United States · North America
Kineticos is a life sciences investment firm that manages several funds, including one targeting lower mid-market pharma services companies and others investing in early-stage life science and antimicrobial resistance innovators. It also provides consulting services to portfolio companies, drawing on in-house scientific, industry and functional expertise.
Invests inHealthcare & Biotech
In its own wordslife sciencespharma servicesantimicrobial resistanceoncologyrare diseasesneuroscience
Your fit with Kineticos
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsKineticos lists 13 checked portfolio companies on its own site. Its largest theme is Healthcare & Biotech (100%). 60% of its companies are based in United States. It invests most often alongside Frontier Path, Avoro Capital Advisors and CincyTech.
No funding round on record names Kineticos yet, so the figures come from its portfolio page.
Round figures show recent activity, not Kineticos' whole history. Rounds on record name 0 companies; its own site lists 13. Funding rounds are complete from mid-2025, so counts and the yearly trend undercount a firm that invested before then. The portfolio, themes and places come from its own site and are not affected.
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 33th | 13 companies |
| Recent activity | 46th | 0 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 59th | 3 countries |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers13100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherCompare Kineticos head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Portfolio
13 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Amylyx develops novel therapies for communities with high unmet needs, including diseases such as post-bariatric hypoglycemia, Wolfram syndrome, and amyotrophic lateral sclerosis. | Healthcare & Biotech | Portfolio page | ||
| Clarametyx is a clinical stage biopharmaceutical company developing novel immune-enabling therapies for serious or difficult-to-treat respiratory diseases. | Healthcare & Biotech | Portfolio page | ||
| DIANT offers equipment and R&D services for nanoparticle production | Healthcare & Biotech | Portfolio page | ||
| EnteroBiotix is a clinical-stage microbiome therapeutics company advancing an orally delivered, full-spectrum microbiome drug for the treatment of irritable bowel syndrome and other diseases linked to the gastrointestinal tract and the liver | Healthcare & Biotech | Portfolio page | ||
| eXmoor Pharma provides cell and gene therapy services, including consulting, process development, analytical services, and GMP manufacturing | Healthcare & Biotech | Portfolio page | ||
| Experic provides clinical trial supply chain services and contract manufacturing services | Healthcare & Biotech | Portfolio page | ||
| InceptorBio is a clinical-stage biotechnology company pioneering next-generation cell therapies to cure cancer | Healthcare & Biotech | Portfolio page | ||
| Kincellis brings together complementary expertise, capabilities, and capacity to create a stronger partner for cell therapy innovators. | Healthcare & Biotech | Portfolio page | ||
| Kinvard Bio is developing a new class of ribosome-targeting antibiotics | Healthcare & Biotech | Portfolio page | ||
| Neuro42 develops portable MRI and AI-powered neurosurgical robotics for medical imaging and diagnosis | Healthcare & Biotech | Portfolio page | ||
| Orthobond is an antimicrobial technology company that has developed proprietary antimicrobial nanosurfaces for various industries, including medical devices and more. | Healthcare & Biotech | Portfolio page | ||
| Promaxo develops a platform for point-of-care MRI guided interventions | Healthcare & Biotech | Portfolio page | ||
| Portfolio page |
About this data
site last read 5 Nov 2026- Site
- kineticos.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Companies checked
- 13
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Kineticos' profile as data
Pull Kineticos' portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/kineticos.com
# also
GET /v1/firms/kineticos.com/portfolio
GET /v1/firms/kineticos.com/coinvestors
GET /v1/firms/kineticos.com/news